| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.91B | — | +11.0% |
| Cost of Revenue | $2.37B | — | +1.3% |
| R&D Expense | $341.0M | — | +1.8% |
| SG&A Expense | $877.0M | — | +16.8% |
| Interest Expense | $36.0M | — | +0.0% |
| Pre-tax Income | $858.0M | — | +9.4% |
| Income Tax | $133.0M | — | +13.7% |
| Net Income | $720.0M | — | +10.4% |
| EPS (Basic) | $1.07 | — | +12.6% |
| EPS (Diluted) | $1.07 | — | +12.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.96B | -56.6% | -2.2% |
| Short-term Investments | $2.0M | -77.8% | +100.0% |
| Accounts Receivable | $7.26B | +48.8% | +7.3% |
| Inventory | $5.20B | -8.2% | +1.4% |
| Current Assets | $17.39B | +0.3% | +4.8% |
| Total Assets | $42.72B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.89B | — | -37.1% |
| Investing Cash Flow | -$77.0M | — | -126.5% |
| Financing Cash Flow | $389.0M | — | -60.9% |
| +1.4% |
| Current Liabilities | $11.85B | -2.2% | +3.2% |
| Long-term Debt | $1.68B | -0.2% | -6.1% |
| Stockholders' Equity | $24.36B | +0.9% | +0.3% |